Donate to Illuminate Contact TSF
Visit us on Facebook Visit us on Twitter Visit us on YouTube Visit us on Instagram Visit us on Linkedin Visit us on Tiktok

PREMIÈRE MONDIALE | La vie c’est tout de suite

Virtual: France , France

Nelly, la quarantaine, vit près de Beauvais en France. Cette professeure en milieu carcéral est une personne très active avec de nombreux amis et passe-temps. Malgré des années d'incertitude jusqu'à […]

TSF’s Human Collective Project | Danmark

Virtual: Danmark , Denmark

The Human Collective Project (HCP) is TSF’s support group meetings offered to anyone who has been affected/impacted by NMOSD/MOGAD. The program came into existence during the height of the COVID-19 […]

Il progetto collettivo umano (HCP) | Italia

Virtual: Italy , Italy

The Human Collective Project (HCP) è l’incontro del gruppo di supporto di TSF offerto a chiunque sia stato colpito/colpito da NMOSD/MOGAD. Il programma è nato durante il culmine della pandemia […]

El proyecto colectivo humano (HCP) | Español

Virtual: Colombia , Colombia

El Human Collective Project (HCP) es la reunión del grupo de apoyo de TSF que se ofrece a cualquier persona que haya sido afectada/impactada por NMOSD/MOG-AD. El programa nació durante […]

Démarches administratives et handicap

Virtual: France , France

Nous vous invitons à rejoindre notre prochain webinaire le lundi 27 mai à 14h00 CET avec Marie Delenne, Patiente Experte Sclérose en Plaques et ancienne Inspectrice du Travail. Démarches administratives […]

Event Series TSF Patient Day

TSF’s Cleveland Patient Day for NMOSD & MOGAD

Cleveland Clinic Administrative Campus Building 4 3175 Science Park Drive, Beachwood, United States

Are you an NMOSD/MOGAD patient, caregiver, clinician, nurse, researcher and/or advocate in or around Ohio? You're invited to our special day! In collaboration with Dr. Amy Kunchok, Dr. Mary Rensel […]

Approved NMOSD Therapies

Virtual: Global

In 2014, there were 0 FDA-approved therapies for patients living with neuromyelitis optica spectrum disorder (NMOSD). In 2024, there are 4 efficacious, FDA-approved therapies available for patients living with NMOSD. […]

Industry Partners

Community Partners

WARNING: Internet Explorer does not support modern web standards. This site may not function correctly on this browser and is best viewed on Chrome, Firefox or Edge browsers. Learn More.